Works matching AU Ganjoo, Kristen

Results: 59
    1
    2
    3
    4
    5
    6

    Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.

    Published in:
    2017
    By:
    • Schuetze, Scott M.;
    • Bolejack, Vanessa;
    • Choy, Edwin;
    • Ganjoo, Kristen N.;
    • Staddon, Arthur P.;
    • Chow, Warren A.;
    • Tawbi, Hussein A.;
    • Samuels, Brian L.;
    • Patel, Shreyaskumar R.;
    • Mehren, Margaret;
    • D'Amato, Gina;
    • Leu, Kirsten M.;
    • Loeb, David M.;
    • Forscher, Charles A.;
    • Milhem, Mohammed M.;
    • Rushing, Daniel A.;
    • Lucas, David R.;
    • Chugh, Rashmi;
    • Reinke, Denise K.;
    • Baker, Laurence H.
    Publication type:
    journal article
    7
    8

    A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 16, p. 2448, doi. 10.1002/cncr.28728
    By:
    • Pappo, Alberto S.;
    • Vassal, Gilles;
    • Crowley, John J.;
    • Bolejack, Vanessa;
    • Hogendoorn, Pancras C. W.;
    • Chugh, Rashmi;
    • Ladanyi, Marc;
    • Grippo, Joseph F.;
    • Dall, Georgina;
    • Staddon, Arthur P.;
    • Chawla, Sant P.;
    • Maki, Robert G.;
    • Araujo, Dejka M.;
    • Geoerger, Birgit;
    • Ganjoo, Kristen;
    • Marina, Neyssa;
    • Blay, Jean‐Yves;
    • Schuetze, Scott M.;
    • Chow, Warren A.;
    • Helman, Lee J.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.

    Published in:
    Acta Orthopaedica, 2021, v. 92, n. 4, p. 493, doi. 10.1080/17453674.2021.1922161
    By:
    • Van De Sande, Michiel;
    • Tap, William D;
    • Gelhorn, Heather L;
    • Ye, Xin;
    • Speck, Rebecca M;
    • Palmerini, Emanuela;
    • Stacchiotti, Silvia;
    • Desai, Jayesh;
    • Wagner, Andrew J;
    • Alcindor, Thierry;
    • Ganjoo, Kristen;
    • Martín-Broto, Javier;
    • Wang, Qiang;
    • Shuster, Dale;
    • Gelderblom, Hans;
    • Healey, John H
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Non-Hodgkin Lymphoma of the Breast.

    Published in:
    Cancer (0008543X), 2007, v. 110, n. 1, p. 25, doi. 10.1002/cncr.22753
    By:
    • Ganjoo, Kristen;
    • Advani, Ranjana;
    • Mariappan, M. Rajan;
    • McMillan, Alex;
    • Horning, Sandra
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1655, doi. 10.1634/theoncologist.2020-0679
    By:
    • Riedel, Richard F.;
    • Ballman, Karla V.;
    • Lu, Yao;
    • Attia, Steven;
    • Loggers, Elizabeth T.;
    • Ganjoo, Kristen N.;
    • Livingston, Michael B.;
    • Chow, Warren;
    • Wright, Jennifer;
    • Ward, John H.;
    • Rushing, Daniel;
    • Okuno, Scott H.;
    • Reed, Damon R.;
    • Liebner, David A.;
    • Keedy, Vicki L.;
    • Mascarenhas, Leo;
    • Davis, Lara E.;
    • Ryan, Christopher;
    • Reinke, Denise K.;
    • Maki, Robert G.
    Publication type:
    Article
    36

    A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 2, p. 1532, doi. 10.1002/cam4.5044
    By:
    • Attia, Steven;
    • Bolejack, Vanessa;
    • Ganjoo, Kristen N.;
    • George, Suzanne;
    • Agulnik, Mark;
    • Rushing, Daniel;
    • Loggers, Elizabeth T.;
    • Livingston, Michael B.;
    • Wright, Jennifer;
    • Chawla, Sant P.;
    • Okuno, Scott H.;
    • Reinke, Denise K.;
    • Riedel, Richard F.;
    • Davis, Lara E.;
    • Ryan, Christopher W.;
    • Maki, Robert G.
    Publication type:
    Article
    37

    Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 2, p. 250, doi. 10.1111/bjh.14667
    By:
    • Martin, Peter;
    • Chen, Zhengming;
    • Cheson, Bruce D.;
    • Robinson, Katherine S.;
    • Williams, Michael;
    • Rajguru, Saurabh A.;
    • Friedberg, Jonathan W.;
    • Jagt, Richard H.;
    • LaCasce, Ann S.;
    • Joyce, Robin;
    • Ganjoo, Kristen N.;
    • Bartlett, Nancy L.;
    • Lemieux, Bernard;
    • VanderWalde, Ari;
    • Herst, Jordan;
    • Szer, Jeffrey;
    • Bar, Michael H.;
    • Cabanillas, Fernando;
    • Dodds, Anthony J.;
    • Montgomery, Paul G.
    Publication type:
    Article
    38
    39

    Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.

    Published in:
    2020
    By:
    • Tap, William D.;
    • Wagner, Andrew J.;
    • Schöffski, Patrick;
    • Martin-Broto, Javier;
    • Krarup-Hansen, Anders;
    • Ganjoo, Kristen N.;
    • Yen, Chueh-Chuan;
    • Abdul Razak, Albiruni R.;
    • Spira, Alexander;
    • Kawai, Akira;
    • Le Cesne, Axel;
    • Van Tine, Brian A.;
    • Naito, Yoichi;
    • Park, Se Hoon;
    • Fedenko, Alexander;
    • Pápai, Zsuzsanna;
    • Soldatenkova, Victoria;
    • Shahir, Ashwin;
    • Mo, Gary;
    • Wright, Jennifer
    Publication type:
    journal article
    40
    41

    Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review.

    Published in:
    Journal of Neurosurgery: Spine, 2024, v. 40, n. 4, p. 485, doi. 10.3171/2023.10.SPINE23666
    By:
    • Zamarud, Aroosa;
    • Marianayagam, Neelan J.;
    • Sekar, Vashisht;
    • Testa, Stefano;
    • Park, David J.;
    • Yener, Ulas;
    • McCleary, Tamra-Lee;
    • Yoo, Kelly H.;
    • Emrich, Sara;
    • Tayag, Armine;
    • Ustrzynski, Louisa;
    • Pollom, Erqi;
    • Soltys, Scott;
    • Lei Wang;
    • Charville, Greg;
    • Ganjoo, Kristen;
    • Chang, Steven D.;
    • Meola, Antonio
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 1, p. 42, doi. 10.3109/10428194.2014.911859
    By:
    • Ganjoo, Kristen N.;
    • de Vos, Sven;
    • Pohlman, Brad L.;
    • Flinn, Ian W.;
    • Forero-Torres, Andres;
    • Enas, Nathan H.;
    • Cronier, Damien M.;
    • Dang, Nam H.;
    • Foon, Kenneth A.;
    • Carpenter, Susan P.;
    • Slapak, Christopher A.;
    • Link, Brian K.;
    • Smith, Mitchell R.;
    • Mapara, Markus Y.;
    • Wooldridge, James E.
    Publication type:
    Article
    48
    49
    50